Kewalramani Reshma 的 Form 4 申報
Vertex Pharmaceuticals IncVRTX，2026/3/3 申報
- 申報編號
- 0000875320-26-000129
- 申報時間
- 2026/3/3
- 交易日
- 2026/2/27
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 13 筆非衍生性交易。公開市場賣出合計 $1,974 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kewalramani ReshmaCIK 0001735944 | 董事、高階主管（執行長、總裁） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/27 | Common Stock | S賣出處分 | −400 | $479.75F2,F3 | −$191,900 | 137,878 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −120 | $481.50F2,F4 | −$57,780 | 137,758 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −240 | $482.84F2,F5 | −$115,881.6 | 137,518 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −2,510 | $487.13F2,F6 | −$1,222,696.3 | 135,008 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −3,278 | $488.27F2,F7 | −$1,600,549.06 | 131,730 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −460 | $489.32F2,F8 | −$225,087.2 | 131,270 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −2,725 | $490.54F2,F9 | −$1,336,721.5 | 128,545 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −949 | $491.30F2,F10 | −$466,243.7 | 127,596 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −2,520 | $493.29F2,F11 | −$1,243,090.8 | 125,076 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −3,498 | $494.33F2,F12 | −$1,729,166.34 | 121,578 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −15,580 | $495.38F2,F13 | −$7,718,020.4 | 105,998 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −5,995 | $496.16F2,F14 | −$2,974,479.2 | 100,003 | 直接 | |
| 2026/2/27 | Common Stock | S賣出處分 | −1,725 | $496.95F2,F15 | −$857,238.75 | 98,278 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
表 I 有 13 筆交易的價格引用這則附註。
- F3
Open market sales reported on this line occurred at a weighted average price of $479.75 (range $479.75 to $479.76).
表 I 有 1 筆交易的價格引用這則附註。
- F4
Open market sales reported on this line occurred at a weighted average price of $481.50 (range $481.50 to $481.51).
表 I 有 1 筆交易的價格引用這則附註。
- F5
Open market sales reported on this line occurred at a weighted average price of $482.84 (range $482.84 to $482.85).
表 I 有 1 筆交易的價格引用這則附註。
- F6
Open market sales reported on this line occurred at a weighted average price of $487.13 (range $486.64 to $487.55).
表 I 有 1 筆交易的價格引用這則附註。
- F7
Open market sales reported on this line occurred at a weighted average price of $488.27 (range $487.82 to $488.56).
表 I 有 1 筆交易的價格引用這則附註。
- F8
Open market sales reported on this line occurred at a weighted average price of $489.32 (range $489.01 to $489.79).
表 I 有 1 筆交易的價格引用這則附註。
- F9
Open market sales reported on this line occurred at a weighted average price of $490.54 (range $490.10 to $491.01).
表 I 有 1 筆交易的價格引用這則附註。
- F10
Open market sales reported on this line occurred at a weighted average price of $491.30 (range $491.13 to $491.85).
表 I 有 1 筆交易的價格引用這則附註。
- F11
Open market sales reported on this line occurred at a weighted average price of $493.29 (range $492.78 to $493.77).
表 I 有 1 筆交易的價格引用這則附註。
- F12
Open market sales reported on this line occurred at a weighted average price of $494.33 (range $493.78 to $494.75).
表 I 有 1 筆交易的價格引用這則附註。
- F13
Open market sales reported on this line occurred at a weighted average price of $495.38 (range $494.79 to $495.78).
表 I 有 1 筆交易的價格引用這則附註。
- F14
Open market sales reported on this line occurred at a weighted average price of $496.16 (range $495.79 to $496.74).
表 I 有 1 筆交易的價格引用這則附註。
- F15
Open market sales reported on this line occurred at a weighted average price of $496.95 (range $496.79 to $497.17).
表 I 有 1 筆交易的價格引用這則附註。